Bank of America’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bank of America’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-75,000	Closed	-$618K	–	7574
2015 Q1	$618K	Buy	75,000 +71,100	+1,823%	+$526K	﹤0.01%	4142
2014 Q4	$27K	Sell	3,900 -91,200	-96%	-$570K	﹤0.01%	6667
2014 Q3	$514K	Buy	95,100 +88,600	+1,363%	+$517K	﹤0.01%	4562
2014 Q2	$41K	Sell	6,500 -32,300	-83%	-$222K	﹤0.01%	6795
2014 Q1	$313K	Sell	38,800 -66,200	-63%	-$516K	﹤0.01%	5030
2013 Q4	$716K	Buy	105,000 +80,500	+329%	+$435K	﹤0.01%	4423
2013 Q3	$451K	Buy	24,500 +15,100	+161%	+$293K	﹤0.01%	4734
2013 Q2	$164K	Buy	+9,400	New	+$167K	﹤0.01%	5812

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Bank of America's ARIA Position: Q1 2017 in Review

Bank of America sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 67,923 shares — an estimated $846K sold.

Bank of America first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $5.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Bank of America reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Bank of America sold 67,923 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $846K.
Bank of America first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Bank of America's Ariad Pharmaceuticals Inc position peaked at $5.5M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.